ZEPOSIA 0.23 mg + 0.46 mg Price

Overview

Welcome to Dwaey, specifically on ZEPOSIA 0.23 mg + 0.46 mg page.
This medicine contains an important and useful components, as it consists of
Ozanimod , Ozanimodis available in the market in concentration

Name

Promethazine Theoclate

Precaution

Before starting **Promethazine Theoclate**, it is essential to consult with a healthcare provider, particularly if the patient has any of the following conditions: - **Respiratory Disorders**: Individuals with **asthma**, **chronic obstructive pulmonary disease (COPD)**, or any other condition that affects respiratory function should exercise caution when using **Promethazine Theoclate**. This drug can cause **respiratory depression**, especially in higher doses, and should be closely monitored in these patients. - **Children**: **Promethazine Theoclate** should **not be used** in children under **2 years of age** due to the risk of **severe respiratory depression**. In children older than 2 years, the medication should be administered with caution. - **Liver and Kidney Disorders**: People with **liver** or **kidney problems** should be cautious when using this medication. **Promethazine Theoclate** is metabolized in the liver and excreted by the kidneys, so patients with impaired function may need a dose adjustment or additional monitoring. - **Neurological Disorders**: **Promethazine Theoclate** can lower the seizure threshold and should be used with caution in patients with a history of **seizures** or **epilepsy**. - **Alcohol Use**: **Promethazine Theoclate** should not be combined with alcohol, as it may increase the sedative effects, leading to excessive drowsiness, dizziness, or respiratory depression. - **Pregnancy and Breastfeeding**: It should be used during **pregnancy** only if the potential benefits outweigh the risks, particularly in the first trimester. **Promethazine Theoclate** passes into breast milk, so its use should be avoided while breastfeeding unless absolutely necessary.

Indication

**Promethazine Theoclate** is primarily used to manage the following conditions: - **Allergic Reactions**: It is effective in treating symptoms of **allergic conditions** such as **hay fever**, **urticaria (hives)**, and **allergic rhinitis**. It helps alleviate symptoms like **itching**, **sneezing**, and **runny nose**. - **Motion Sickness**: Used to prevent **nausea**, **vomiting**, and **dizziness** associated with **motion sickness**, particularly in individuals who are prone to travel-related nausea. - **Nausea and Vomiting**: **Promethazine Theoclate** is used to treat **nausea** and **vomiting** due to a variety of causes, including **gastroenteritis**, **postoperative recovery**, and **chemotherapy**. - **Sedation**: Due to its sedative properties, **Promethazine Theoclate** is often used as a **preoperative sedative** or as a **sleep aid** for individuals experiencing anxiety or trouble sleeping. - **Preoperative and Postoperative Sedation**: In surgical settings, **Promethazine Theoclate** is often used to **sedate** patients before a procedure or to manage nausea and vomiting after surgery. - **Anaphylaxis**: **Promethazine Theoclate** can be used in the management of **anaphylaxis** in conjunction with other treatments such as epinephrine, particularly for **allergic reactions**.

Contra indication

The use of **Promethazine Theoclate** is contraindicated in the following situations: - **Hypersensitivity**: Patients with a known allergy to **Promethazine** or any of its excipients should avoid using this medication. - **Children Under 2 Years**: **Promethazine Theoclate** is **contraindicated** in children under **2 years old** due to the risk of **severe respiratory depression** and **sedation**, which can be life-threatening. - **Comatose or Sedated Individuals**: Patients who are in a **coma** or have severe **sedation** should not be given **Promethazine Theoclate** due to the risk of exacerbating these conditions. - **Severe Respiratory Depression**: This drug is contraindicated in individuals with **severe respiratory depression** or those with conditions that make them more vulnerable to respiratory problems. - **Severe Liver Disease**: **Promethazine Theoclate** is contraindicated in patients with **severe hepatic impairment**, as the liver metabolizes the drug, and impaired liver function could lead to increased levels and toxicity. - **Bone Marrow Suppression**: Patients with conditions like **bone marrow suppression** or blood disorders should not use **Promethazine Theoclate**, as it may exacerbate the condition.

Side Effect

Like other antihistamines, **Promethazine Theoclate** can cause both common and serious side effects. Some of these include: - **Common Side Effects**: - **Drowsiness**: A frequent and expected effect of **Promethazine Theoclate** is **drowsiness**, which can impair daily activities like driving or operating machinery. - **Dry Mouth**: The anticholinergic effects of **Promethazine Theoclate** can cause **dry mouth**, making it difficult to swallow or speak comfortably. - **Dizziness**: Some patients experience **dizziness**, especially when standing up quickly or after a dose of the medication. - **Blurred Vision**: Temporary **blurred vision** or difficulty focusing can occur due to the anticholinergic effects. - **Constipation**: This medication may cause **constipation** due to its anticholinergic properties. - **Serious Side Effects**: - **Severe Allergic Reactions**: **Anaphylaxis** is a rare but severe allergic reaction that may occur, characterized by **difficulty breathing**, **swelling of the throat**, and **rash**. - **Respiratory Depression**: Especially in children under 2 years old or individuals with pre-existing respiratory conditions, **Promethazine Theoclate** can lead to life-threatening **respiratory depression**. - **Extrapyramidal Symptoms**: Uncommon, but **tremors**, **rigidity**, and other **movement disorders** can occur, especially at high doses or prolonged use. - **Neuroleptic Malignant Syndrome (NMS)**: A life-threatening condition that includes symptoms such as **muscle rigidity**, **high fever**, and **altered mental status**. - **Severe Sedation**: In some individuals, particularly with overdose or in combination with other CNS depressants, **Promethazine Theoclate** can cause excessive sedation or even coma.

Pregnancy Category ID

3

Mode of Action

**Promethazine Theoclate** is an **antihistamine** with multiple therapeutic effects. The mechanism of action includes: - **Histamine Receptor Blockade**: **Promethazine Theoclate** primarily works by blocking **H1 histamine receptors** in the brain and body. Histamine is a neurotransmitter that plays a key role in allergic reactions. By blocking its action, **Promethazine Theoclate** reduces allergy symptoms such as **itching**, **sneezing**, and **runny nose**. - **CNS Sedation**: The drug also crosses the **blood-brain barrier** and binds to **histamine receptors** in the brain, resulting in **sedation**. This sedative effect makes it useful as a **sleep aid** and **preoperative sedative**. - **Antiemetic Action**: **Promethazine Theoclate** blocks receptors in the **vomiting center** of the brain, helping to **reduce nausea** and **vomiting**, making it effective for motion sickness, chemotherapy-induced nausea, and postoperative nausea. - **Anticholinergic Effects**: The drug has additional **anticholinergic properties**, which contribute to its effects in reducing nausea and vomiting, as well as side effects like **dry mouth**, **constipation**, and **blurred vision**.

Interaction

**Promethazine Theoclate** has several interactions that can affect its efficacy or safety. Key interactions include: - **CNS Depressants**: Combining **Promethazine Theoclate** with other **central nervous system (CNS) depressants**, such as **alcohol**, **benzodiazepines**, **opioids**, and other sedative-hypnotics, can lead to **increased sedation**, **drowsiness**, or **respiratory depression**. This combination should be avoided or carefully monitored. - **Monoamine Oxidase Inhibitors (MAOIs)**: The combination of **Promethazine Theoclate** with **MAOIs** (used in treating depression) can increase the risk of **hypertensive crises** and other side effects. It is generally recommended to avoid this combination. - **Antihypertensive Medications**: **Promethazine Theoclate** may increase the sedative effects of **antihypertensive** drugs, leading to a further decrease in **blood pressure** or causing dizziness and fainting. - **Anticholinergic Drugs**: As **Promethazine Theoclate** has anticholinergic properties, combining it with other **anticholinergic drugs** (such as **antihistamines**, **antidepressants**, or **antipsychotics**) may result in an increased risk of side effects like **dry mouth**, **blurred vision**, and **urinary retention**. - **Warfarin (Blood Thinners)**: **Promethazine Theoclate** may interact with **warfarin** (a blood thinner), affecting its efficacy. Patients on **warfarin** should have their **INR levels** monitored closely when starting or stopping **Promethazine Theoclate**.

Pregnancy Category Note

Information not available

Adult Dose

The typical adult doses of **Promethazine Theoclate** are as follows: - **Allergic Conditions**: For **allergic reactions**, a dose of **12.5-25 mg orally** is usually given, either once daily or divided into two doses. - **Motion Sickness**: For prevention, a dose of **25 mg orally** should be taken 30 to 60 minutes before traveling. It may be repeated every 6-8 hours as needed. - **Nausea and Vomiting**: The usual dose for treating **nausea** and **vomiting** is **12.5-25 mg orally** or **rectally** every 4-6 hours, as needed. - **Preoperative Sedation**: A dose of **25-50 mg** is typically administered **1 hour before** the procedure.

Child Dose

For pediatric patients, **Promethazine Theoclate** should be used cautiously and at lower doses: - **Children (2-5 years)**: The typical dose is **6.25 mg** every 4-6 hours, not exceeding **25 mg/day**. - **Children (6-12 years)**: The usual dose is **12.5-25 mg** every 4-6 hours, not exceeding **75 mg/day**. - **Adolescents (13-16 years)**: **25 mg** every 4-6 hours, not exceeding **75 mg/day**. As with all medications, doses should be carefully tailored to each child’s weight and medical needs, and a healthcare provider should always be consulted.

Renal Dose

In patients with **renal impairment**, **Promethazine Theoclate** should be used with caution. Since it is primarily metabolized in the liver and excreted through the kidneys, dosing adjustments may be required in those with severe **renal dysfunction**. Monitoring is recommended for these patients.

Administration

Information not available